Sensus Healthcare, Inc. (SRTS) shares ended the last trading session 7.9% higher at $7.34. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 20.9% loss over the past four weeks.Sensus Healthcare scored a strong price increase driven by the optimism surrounding the company’s announcement of third-quarter 2024 results. The company reported quarterly earnings of 7 cents per share, which beat the Zacks Consensus Estimate ...

Sensus Healthcare, Inc. (SRTS) closed the last trading session at $8.58, gaining 31% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $11.67 indicates a 36% upside potential.The average comprises three short-term price targets ranging from a low of $10 to a high of $14, with a standard deviation of $2.08. While the lowest estimate indicates an increase of 16.6% from the current pric ...

Exhibit 99.1 TECHNOLOGY THAT CAR Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter ● Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year ago ● Signed a Fair Deal Agreement with Platinum Dermatology, a leading dermatology network with 130 clinics across the U.S. Conference call begins at 4:30 p.m. Eastern time today B ...

Sensus Healthcare, Inc. (SRTS) closed the last trading session at $7.64, gaining 14.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $10.67 indicates a 39.7% upside potential.The average comprises three short-term price targets ranging from a low of $10 to a high of $12, with a standard deviation of $1.15. While the lowest estimate indicates an increase of 30.9% from the current ...

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it.The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the stock alive.Inves ...

This revised news release replaces the one issued on November 14, 2024, contains several non-financial changes throughout and removes the name of and references to a new customer, at the customer’s request. The agreement with the new customer remains in effect. Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year ago Expects to have more than 50 IG-SRT Systems signed under the Fair Deal A ...

Sensus Healthcare (NASDAQ: SRTS ) is a company that develops equipment to treat skin problems, including non-melanoma cancer. I had previously covered the company in which I commented that the initiatives to generate recurring revenue wereMy name is María Fernanda and I am currently studying an MBA. My inspiration investors are Warren Buffett, Peter Lynch and Terry Smith, so I look for quality companies at a reasonable valuation. I believe that, in the long term, fundamentals are what drive the share price, ...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET Company Participants Kim Golodetz - Alliance Advisors IR Joseph Sardano - Chairman and CEO Michael Sardano - President and General Counsel Javier Rampolla - CFO Conference Call Participants Jason Wittes - ROTH Anthony Vendetti - Maxim Ilya Zubkov - Freedom Broker Jade Montgomery - H.C. Wainwright Operator Good afternoon and welcome to the Sensus Healthcare Third Quarter 2024 Financial Results Conference Call. ...

Sensus Healthcare, Inc. (SRTS) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 450%. A quarter ago, it was expected that this company would post earnings of $0.03 per share when it actually produced earnings of $0.10, delivering a surprise of 233.33%.Over the last four quarters, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Title of each class Trading symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share SRTS The NASDAQ Stock Market, LLC FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ___________ ...